Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma [corrected]
- PMID: 2785642
- DOI: 10.1056/NEJM198905253202117
Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma [corrected]
Erratum in
- N Engl J Med 1989 Jul 6;321(1):63
Similar articles
-
[T lymphocyte activation induced in vivo by the first injection of OKT3 monoclonal antibodies].C R Acad Sci III. 1988;307(19):833-6. C R Acad Sci III. 1988. PMID: 3146414 French.
-
Cascade modulation by anti-tumor necrosis factor monoclonal antibody of interferon-gamma, interleukin 3 and interleukin 6 release after triggering of the CD3/T cell receptor activation pathway.Eur J Immunol. 1991 Oct;21(10):2349-53. doi: 10.1002/eji.1830211009. Eur J Immunol. 1991. PMID: 1833202
-
Human gamma interferon production by leukocytes induced with monoclonal antibodies recognizing T cells.J Immunol. 1981 Sep;127(3):1197-200. J Immunol. 1981. PMID: 6167620
-
Acute toxicity of anti-CD3 monoclonal antibody in mice: a model for OKT3 first dose reactions.Transplant Proc. 1990 Aug;22(4):1920-1. Transplant Proc. 1990. PMID: 2143864 No abstract available.
-
OKT3 monoclonal antibody induces production of colony-stimulating factor(s) for granulocytes and macrophages in cultures of human T lymphocytes and adherent cells.J Immunol. 1985 Jan;134(1):265-71. J Immunol. 1985. PMID: 3917276
Cited by
-
Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity.Int J Mol Sci. 2020 May 8;21(9):3330. doi: 10.3390/ijms21093330. Int J Mol Sci. 2020. PMID: 32397174 Free PMC article. Review.
-
Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass.Diabetologia. 2010 Apr;53(4):614-23. doi: 10.1007/s00125-009-1644-9. Epub 2010 Jan 14. Diabetologia. 2010. PMID: 20225393 Clinical Trial.
-
Cytokine storm syndrome in coronavirus disease 2019: A narrative review.J Intern Med. 2021 Feb;289(2):147-161. doi: 10.1111/joim.13144. Epub 2020 Jul 22. J Intern Med. 2021. PMID: 32696489 Free PMC article. Review.
-
A rapid, sensitive, and reproducible in vivo PBMC humanized murine model for determining therapeutic-related cytokine release syndrome.FASEB J. 2020 Sep;34(9):12963-12975. doi: 10.1096/fj.202001203R. Epub 2020 Aug 9. FASEB J. 2020. PMID: 32772418 Free PMC article.
-
Isotype-specific cross-linking of select human Fc gamma R isoforms triggers release of IL-6.Clin Exp Immunol. 1993 May;92(2):225-31. doi: 10.1111/j.1365-2249.1993.tb03384.x. Clin Exp Immunol. 1993. PMID: 8485907 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources